Aged CD8+ T Cells Circulating in Blood Directly Cause Age-Related Memory Loss
A landmark study identifies aged cytotoxic T cells and their secreted factor Granzyme K as key drivers of cognitive decline — and shows removing them restores memory.
Summary
Researchers at UCSF demonstrated that aged CD8+ T cells circulating in blood — not just those infiltrating the brain — directly drive hippocampal-dependent cognitive decline in mice. Using heterochronic parabiosis, the team showed these immune cells retain age-intrinsic properties regardless of systemic environment. Exposing young mice to aged CD8+ T cells impaired cognition and altered synaptic gene expression in the hippocampus. Crucially, inhibiting T cell activation (not brain infiltration) reversed these effects. Depleting aged CD8+ T cells or blocking their secreted factor Granzyme K (GZMK) rescued cognition in old mice. GZMK was detected in human plasma and increased with age, suggesting a translatable therapeutic target for age-related cognitive decline.
Detailed Summary
Cognitive decline is a defining feature of aging, yet its immune underpinnings remain incompletely understood. While brain-infiltrating T cells have received attention, the role of non-infiltrating, circulating aged CD8+ T cells in driving brain aging had not been fully defined — until now.
Researchers led by Juliana Sucharov and Saul Villeda at UCSF used heterochronic parabiosis — surgically joining young and old mice to share circulation — combined with transcriptomic analysis to show that peripheral CD8+ T cells maintain age-intrinsic transcriptional properties even when exposed to a young systemic environment. This finding challenges the assumption that circulating immune cells can be fully 'rejuvenated' by young blood.
To establish causality, the team systemically exposed young mice to aged CD8+ T cells. This alone was sufficient to produce synaptic-related gene expression changes in the hippocampus and impair performance on hippocampal-dependent cognitive tasks. Importantly, blocking T cell activation — but not their physical infiltration into the brain — was sufficient to mitigate these pro-aging effects, indicating the mechanism is secretion-dependent rather than cell-contact-dependent.
Conversely, selectively depleting aged CD8+ T cells from old mice restored youthful hippocampal gene signatures and rescued cognitive performance. Through proteomic and transcriptomic approaches, Granzyme K (GZMK) was identified as a key secreted factor from aged CD8+ T cells elevated in plasma. Pharmacological inhibition of GZMK in aged animals rescued cognition, positioning it as a tractable therapeutic target. Notably, GZMK levels in human plasma also increase with age, strengthening translational relevance.
These findings reframe peripheral immune aging as a direct contributor to brain aging through circulating factors, not merely as a bystander process. They open therapeutic avenues targeting circulating immune-derived molecules — particularly GZMK — to combat age-related cognitive decline without requiring direct CNS intervention.
Key Findings
- Aged CD8+ T cells retain age-intrinsic transcriptional properties even in young systemic circulation via parabiosis.
- Systemic exposure of young mice to aged CD8+ T cells impairs hippocampal-dependent cognition and alters synaptic gene expression.
- T cell activation — not brain infiltration — mediates pro-aging cognitive effects, implicating secreted factors.
- Depleting aged CD8+ T cells in old mice restores youthful hippocampal signatures and rescues memory.
- Granzyme K (GZMK), elevated in aged mouse and human plasma, is a causative secreted factor; its inhibition rescues cognition.
Methodology
The study used heterochronic parabiosis in mice, adoptive transfer of aged CD8+ T cells into young recipients, targeted depletion of aged CD8+ T cells, and pharmacological GZMK inhibition. Outcomes included transcriptomic profiling (RNAseq) of hippocampal tissue and hippocampal-dependent behavioral cognitive assessments.
Study Limitations
All mechanistic experiments were conducted in mice, and direct causal evidence in humans is lacking. The precise molecular pathway through which circulating GZMK affects hippocampal synaptic function remains to be fully elucidated. Long-term consequences of CD8+ T cell depletion or GZMK inhibition on immune defense were not characterized.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: